Primer: Vigonvita Life Sciences (VVL HK) - Aug 2026
Vigonvita Life Sciences is an innovation-focused biopharmaceutical company with a strategic emphasis on neuropsychiatric, infectious, and...
95 Views
Vigonvita Life Sciences (旺山旺水) Pre-IPO: Window Dressing
Vigonvita aims to raise over US$100 million in Hong Kong listing with CITIC as book runner. In this note we note the company dropped anti-viral...
471 Views
Pre-IPO Vigonvita Life Sciences (PHIP Updates) - Some Points Worth the Attention
Vigonvita's short-term product revenue outlook is uncertain, with concerns on IPO fundraising rational.If TPN171 sales is poor or clinical trial...
430 Views
APAC Healthcare Weekly (March 29) – Hansoh, CSPC, Chugai, Takeda, Otsuka, Celltrion, Alteogen
Hansoh got trial approval, while CSPC obtained new drug approval. Chugai’s partner is discontinuing development of emugrobart. Otsuka is acquiring...
336 Views
APAC Healthcare Weekly (December 7) – Simcere, Kelun Bio, Samsung Biologics, Daiichi Sankyo, Biocon
Simcere stuck license pact with Vigonvita. Kelun Bio inked partnership with Crescent Biopharma. Samsung Biologics is acquiring land for third...
634 Views